Literature DB >> 15159294

Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation.

Carlo Pappone1, Hakan Oral, Vincenzo Santinelli, Gabriele Vicedomini, Christopher C Lang, Francesco Manguso, Lucia Torracca, Stefano Benussi, Ottavio Alfieri, Robert Hong, William Lau, Kirk Hirata, Neil Shikuma, Burr Hall, Fred Morady.   

Abstract

BACKGROUND: Radiofrequency ablation for atrial fibrillation is becoming widely practiced. METHODS AND
RESULTS: Two patients undergoing circumferential pulmonary vein ablation for atrial fibrillation in different centers developed symptoms compatible with endocarditis 3 to 5 days after the procedure. Their clinical condition deteriorated rapidly, and both suffered multiple gaseous and/or septic embolic events causing cerebral and myocardial damage. One patient survived after emergency cardiac and esophageal surgery; the other died of extensive systemic embolization. An atrio-esophageal fistula was identified in both patients.
CONCLUSIONS: Atrio-esophageal fistulas can occur after catheter ablation in the posterior wall of the left atrium. This diagnosis should be excluded in any patient with symptoms or signs of endocarditis after left atrial ablation, and expeditious cardiac surgery is critical if the diagnosis is confirmed. Lower power and temperature settings for applications of radiofrequency energy along the posterior left atrial wall may prevent further cases of fistula formation.

Entities:  

Mesh:

Year:  2004        PMID: 15159294     DOI: 10.1161/01.CIR.0000131866.44650.46

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  169 in total

1.  Measuring luminal esophageal temperature during pulmonary vein isolation of atrial fibrillation.

Authors:  Daisuke Sato; Kunihiro Teramoto; Hiroki Kitajima; Naoto Nishina; Yoshitomi Kida; Hiroki Mani; Masahiro Esato; Yeong-Hwa Chun; Toshiji Iwasaka
Journal:  World J Cardiol       Date:  2012-05-26

2.  Pulmonary vein isolation using a compliant endoscopic laser balloon ablation system in a swine model.

Authors:  Edward P Gerstenfeld; John Michele
Journal:  J Interv Card Electrophysiol       Date:  2010-07-13       Impact factor: 1.900

3.  Visualization of the esophagus during catheter ablation of atrial fibrillation.

Authors:  Burr Hall; Abrar Shah; David Huang; Spencer Rosero; James Daubert
Journal:  J Interv Card Electrophysiol       Date:  2005-07       Impact factor: 1.900

Review 4.  Surgical ablation of atrial fibrillation.

Authors:  A Marc Gillinov
Journal:  J Interv Card Electrophysiol       Date:  2005-07       Impact factor: 1.900

5.  Curative catheter ablation for atrial fibrillation.

Authors:  Eric D Good; Hakan Oral
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-10

6.  Epicardial radiofrequency ablation of ventricular myocardium: factors affecting lesion formation and damage to adjacent structures.

Authors:  Guilherme Fenelon; Kleber Ponzi Pereira; Angelo A V de Paola
Journal:  J Interv Card Electrophysiol       Date:  2006-01       Impact factor: 1.900

7.  Posterior left atrial-esophageal relationship throughout the cardiac cycle.

Authors:  Jasbir Sra; David Krum; Angela Malloy; Atul Bhatia; Ryan Cooley; Zalmen Blanck; Anwer Dhala; Alfred J Anderson; Masood Akhtar
Journal:  J Interv Card Electrophysiol       Date:  2006-11-14       Impact factor: 1.900

Review 8.  What Is the Appropriate Lesion Set for Ablation in Patients with Persistent Atrial Fibrillation?

Authors:  Jorge Romero; Carola Gianni; Andrea Natale; Luigi Di Biase
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

9.  Variation in left atrial transmural wall thickness at sites commonly targeted for ablation of atrial fibrillation.

Authors:  Burr Hall; Vinodh Jeevanantham; Rochelle Simon; John Filippone; Gabriel Vorobiof; James Daubert
Journal:  J Interv Card Electrophysiol       Date:  2007-01-17       Impact factor: 1.900

Review 10.  Evidence-based approach to ablating atrial fibrillation.

Authors:  Takumi Yamada; G Neal Kay
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.